These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18305431)

  • 1. Application of prodrugs to inflammatory diseases of the gut.
    Oz HS; Ebersole JL
    Molecules; 2008 Feb; 13(2):452-74. PubMed ID: 18305431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment.
    Qiu L; Shen R; Wei L; Xu S; Xia W; Hou Y; Cui J; Qu R; Luo J; Cao J; Yang J; Sun J; Ma R; Yu Q
    J Nanobiotechnology; 2023 Sep; 21(1):344. PubMed ID: 37741962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Orally Administered Cascade Nanozyme for Inflammatory Bowel Disease Therapy.
    Yu Y; Zhao X; Xu X; Cai C; Tang X; Zhang Q; Zhong L; Zhou F; Yang D; Zhu Z
    Adv Mater; 2023 Nov; 35(44):e2304967. PubMed ID: 37608768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier.
    Mao A; Zhao W; Zhu Y; Kong F; Chen D; Si H; Xu C
    Microorganisms; 2024 Jan; 12(1):. PubMed ID: 38258029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.
    Azman M; Sabri AH; Anjani QK; Mustaffa MF; Hamid KA
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of gastric and bowel surgery on gastrointestinal drug delivery.
    Hua S; Lye EC
    Drug Deliv Transl Res; 2023 Jan; 13(1):37-53. PubMed ID: 35585472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.
    Honig G; Larkin PB; Heller C; Hurtado-Lorenzo A
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S1-S16. PubMed ID: 34791292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.
    Hua S
    Front Pharmacol; 2020; 11():524. PubMed ID: 32425781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab.
    Chen AY; Oz HS
    Diseases; 2019 Sep; 7(4):. PubMed ID: 31569333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiome and Response to Cardiovascular Drugs.
    Tuteja S; Ferguson JF
    Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Role of Green Tea Polyphenols in Improving Fertility: A Review.
    Rahman SU; Huang Y; Zhu L; Feng S; Khan IM; Wu J; Li Y; Wang X
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches.
    Rahman SU; Li Y; Huang Y; Zhu L; Feng S; Wu J; Wang X
    Inflammopharmacology; 2018 Apr; 26(2):319-330. PubMed ID: 29532213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Inflammatory Diseases and Green Tea Polyphenols.
    Oz HS
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Nanofibers of Self-assembled
    Zhou J; O'Keeffe M; Liao G; Zhao F; Terhorst C; Xu B
    Tetrahedron; 2016 Oct; 72(40):6078-6083. PubMed ID: 28216796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
    Moeinian M; Ghasemi-Niri SF; Mozaffari S; Abdolghaffari AH; Baeeri M; Navaea-Nigjeh M; Abdollahi M
    World J Gastroenterol; 2014 Aug; 20(31):10876-85. PubMed ID: 25152589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon.
    Oz HS
    Front Microbiol; 2014; 5():385. PubMed ID: 25104952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models.
    Oz HS; Chen T; de Villiers WJ
    Front Immunol; 2013; 4():132. PubMed ID: 23761791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a metagenomic view of xenobiotic metabolism.
    Haiser HJ; Turnbaugh PJ
    Pharmacol Res; 2013 Mar; 69(1):21-31. PubMed ID: 22902524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin ablation attenuates progression of colitis in TNBS model.
    Oz HS; Zhong J; de Villiers WJ
    Dig Dis Sci; 2012 Jun; 57(6):1554-61. PubMed ID: 22173746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GREEN TEA POLYPHENOLS MEDIATED APOPTOSIS IN INTESTINAL EPITHELIAL CELLS BY A FADD-DEPENDENT PATHWAY.
    Oz HS; Ebersole JL
    J Cancer Ther; 2010 Sep; 1(3):105-113. PubMed ID: 21687829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.